D. Kohn
Molecular Biology · with Dunbar · 2018
A researcher in the Science corpus: 1 paper; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 49 citations into it
- Genetics — 33 citations into it
- Oncology — 26 citations into it
Whom D. Kohn trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- L. Naldini (in Molecular Biology)
- Michel Sadelain (in Oncology)
- I. Rivière (in Oncology)
Papers from D. Kohn's perspective
Ordered by how strongly the researchers D. Kohn trusts endorse each paper. Same corpus, a different order for every researcher.
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia (New England Journal of Medicine)
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors (Science)
- RNA-Guided Human Genome Engineering via Cas9
- Targeting DNA Double-Strand Breaks with TAL Effector Nucleases (Genetics)
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
- A Simple Cipher Governs DNA Recognition by TAL Effectors (Science)
- CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes (Cell)
- Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. (Cell)
- Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection (Nature)
Their papers
- Gene therapy comes of age (2018) — 1,212 citations